Literature DB >> 24082520

Seroprevalence of Toxoplasma gondii in southern districts of Tamil Nadu using IgG-ELISA.

G Sucilathangam1, N Palaniappan, C Sreekumar, T Anna.   

Abstract

The present study was conducted to assess the seroprevalence of Toxoplasma gondii in and around Tirunelveli by in-house IgG assay using ELISA. Serum samples from 175 immunodeficient and 175 immunocompetent patients were collected at Tirunelveli district, Tamil Nadu from May 2006 to October 2007. They were subjected into in-house IgG assay using enzyme-linked immune sorbent assay (ELISA) in which tachyzoite soluble antigen derived from solubilised whole organisms was used. Out of 350 patients tested by IgG ELISA, 46 patients (13.14%) had antibodies for toxoplasmosis with mean OD value of 0.2 ± 0.073 and the OD value ranged from 0.144 to 0.444. Among the immunocompetent group of 175 patients, 19 patients (10.86%) had antibodies to toxoplasmosis whereas, in immunodeficient group of 175 patients, 27 patients (15.43%) had antibodies for toxoplasmosis. There was no statistical difference (P > 0.05) between the immunocompetent and immunodeficient group. The sensitivity and specificity of IgG ELISA in detecting toxoplasmosis was 90 and 100%, respectively. The overall seroprevalence of toxoplasmosis in and around Tirunelveli district of Tamil Nadu was 13.14% based on IgG ELISA. The study has proved ELISA to be a sensitive and specific procedure for the serodiagnosis of toxoplasmosis.

Entities:  

Keywords:  Enzyme-linked immunosorbent assay (ELISA); Seroprevalence; Tamil Nadu; Toxoplasma gondii

Year:  2012        PMID: 24082520      PMCID: PMC3427661          DOI: 10.1007/s12639-012-0103-6

Source DB:  PubMed          Journal:  J Parasit Dis        ISSN: 0971-7196


  27 in total

1.  Seroprevalence of toxoplasma infection among primigravid women attending antenatal clinic at a secondary level hospital in North India.

Authors:  Brogen Singh Akoijam; Sarman Singh; S K Kapoor
Journal:  J Indian Med Assoc       Date:  2002-10

2.  Identification of an apically-located antigen that is conserved in sporozoan parasites.

Authors:  D W Taylor; C B Evans; S B Aley; J R Barta; H D Danforth
Journal:  J Protozool       Date:  1990 Nov-Dec

3.  Chimeric antigens of Toxoplasma gondii: toward standardization of toxoplasmosis serodiagnosis using recombinant products.

Authors:  Elisa Beghetto; Andrea Spadoni; Luca Bruno; Wilma Buffolano; Nicola Gargano
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

4.  Prevalence of torch infections in Indian pregnant women.

Authors:  S Singh
Journal:  Indian J Med Microbiol       Date:  2002 Jan-Mar       Impact factor: 0.985

5.  A microplate enzyme-immunoassay for toxoplasma antibody.

Authors:  A Voller; D E Bidwell; A Bartlett; D G Fleck; M Perkins; B Oladehin
Journal:  J Clin Pathol       Date:  1976-02       Impact factor: 3.411

6.  Evaluation of seven commercially available ELISA kits for serodiagnosis of acute toxoplasmosis.

Authors:  S Singh; N Singh; S N Dwivedi
Journal:  Indian J Med Res       Date:  1997-03       Impact factor: 2.375

Review 7.  A decade of discoveries in veterinary protozoology changes our concept of "subclinical" toxoplasmosis.

Authors:  Milton M McAllister
Journal:  Vet Parasitol       Date:  2005-09-30       Impact factor: 2.738

8.  High TORCH seroprevalence rate in multiply transfused beta thalassemic children in India.

Authors:  S Singh; S Ahalawat; N Singh; V P Chaudhary
Journal:  Eur J Haematol       Date:  1995-01       Impact factor: 2.997

9.  Toxoplasma seroprevalence in healthy voluntary blood donors from urban Karnataka.

Authors:  P Sundar; A Mahadevan; R S Jayshree; D K Subbakrishna; S K Shankar
Journal:  Indian J Med Res       Date:  2007-07       Impact factor: 2.375

Review 10.  Diagnostic evaluation of mononucleosis-like illnesses.

Authors:  Christopher Hurt; Dominick Tammaro
Journal:  Am J Med       Date:  2007-10       Impact factor: 4.965

View more
  1 in total

1.  Seroprevalence of Toxoplasma gondii in newly diagnosed HIV seropositive patients.

Authors:  Anuja Dutta; Preeti R Mehta; Nayana Ingole
Journal:  Indian J Med Res       Date:  2020-11       Impact factor: 2.375

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.